Stock Scorecard
Stock Summary for Harvard Bioscience Inc (HBIO) - $3.82 as of 5/2/2024 7:21:46 PM EST
Total Score
6 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HBIO
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HBIO
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HBIO
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for HBIO
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for HBIO
Financial Details for HBIO
Company Overview |
|
---|---|
Ticker | HBIO |
Company Name | Harvard Bioscience Inc |
Country | USA |
Description | Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery, and preclinical testing for drug development. The company is headquartered in Holliston, Massachusetts. |
Sector Name | LIFE SCIENCES |
Industry Name | LABORATORY ANALYTICAL INSTRUMENTS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/14/2024 |
Stock Price History |
|
Last Day Price | 3.82 |
Last Day Price Updated | 5/2/2024 7:21:46 PM EST |
Last Day Volume | 141,752 |
Average Daily Volume | 98,625 |
52-Week High | 6.28 |
52-Week Low | 3.44 |
Last Price to 52 Week Low | 11.05% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 38.70 |
Sector PE | 54.24 |
5-Year Average PE | 22.75 |
Free Cash Flow Ratio | 38.20 |
Industry Free Cash Flow Ratio | 130.99 |
Sector Free Cash Flow Ratio | 31.75 |
Current Ratio Most Recent Quarter | 1.85 |
Total Cash Per Share | 0.10 |
Book Value Per Share Most Recent Quarter | 1.68 |
Price to Book Ratio | 2.53 |
Industry Price to Book Ratio | 1,002.40 |
Sector Price to Book Ratio | 22.23 |
Price to Sales Ratio Twelve Trailing Months | 1.64 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.02 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.15 |
Share Statistics |
|
Total Shares Outstanding | 43,421,300 |
Market Capitalization | 165,869,366 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.43% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | -80.30% |
Annual Earnings Growth | 64.11% |
Reported EPS 12 Trailing Months | -0.08 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 0.15 |
Net Income Twelve Trailing Months | -3,415,000 |
Net Income Past Year | -3,415,000 |
Net Income Prior Year | -9,516,000 |
Quarterly Revenue Growth YOY | -1.00% |
5-Year Revenue Growth | -1.41% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 4,283,000 |
Total Cash Past Year | 4,283,000 |
Total Cash Prior Year | 4,508,000 |
Net Cash Position Most Recent Quarter | -32,280,000 |
Net Cash Position Past Year | -32,280,000 |
Long Term Debt Past Year | 36,563,000 |
Long Term Debt Prior Year | 46,824,000 |
Total Debt Most Recent Quarter | 36,563,000 |
Equity to Debt Ratio Past Year | 0.67 |
Equity to Debt Ratio Most Recent Quarter | 0.67 |
Total Stockholder Equity Past Year | 73,074,000 |
Total Stockholder Equity Prior Year | 72,220,000 |
Total Stockholder Equity Most Recent Quarter | 73,074,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.18 |
MACD Signal | -0.12 |
20-Day Bollinger Lower Band | 3.50 |
20-Day Bollinger Middle Band | 4.43 |
20-Day Bollinger Upper Band | 5.36 |
Beta | 1.45 |
RSI | 35.97 |
50-Day SMA | 4.66 |
200-Day SMA | 4.81 |
System |
|
Modified | 5/2/2024 1:58:32 AM EST |